CDEK
← All drugs Report issue

sasanlimab

mAbexperimental

Clinical trial activity

25 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
18
Phase 2
9
Phase 3
2
Phase 4
0

Earliest trial started Dec 30, 2015 (NCT02616185)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • pf-06801591

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07123090Phase 2Feb 28, 2026Harvard University, Pfizer
NCT07206225Phase 1Nov 6, 2025Pfizer
NCT06870487Phase 1May 8, 2025Pfizer
NCT06974734Phase 1May 6, 2025Pfizer
NCT06704724Phase 1Jan 13, 2025Pfizer
NCT06580938Phase 1Nov 1, 2024Pfizer
NCT06546553Phase 1Sep 6, 2024Pfizer
NCT06218069Phase 2/Phase 3 (Phase 3)Aug 31, 2024ImaginAb, Inc., Pfizer, Radboud University, University of Tuebingen
NCT06448364Phase 1May 9, 2024Pfizer
NCT06285097Phase 1Feb 8, 2024Pfizer
NCT05935748Phase 2Jul 28, 2023NiKang Therapeutics, Inc., Pfizer
NCT06089265Phase 2Jun 15, 2023Maastricht University, Pfizer
NCT05665361Phase 1/Phase 2 (Phase 2)Dec 29, 2022National Cancer Institute (NCI)
NCT05259397Phase 1Mar 24, 2022Pfizer
NCT05233436Phase 1Feb 24, 2022Pfizer
NCT05241340Phase 2Feb 15, 2022Pfizer, The University of Texas, Dallas
NCT05061537Phase 1Oct 20, 2021Pfizer
NCT04585815Phase 1/Phase 2 (Phase 2)Nov 10, 2020Pfizer
NCT04181788Phase 2Feb 28, 2020Pfizer
NCT04165317Phase 3Dec 23, 2019Pfizer
Showing 20 of 25 trials
Page 1 / 2

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit231832015
Harvard UniversityAcademic/Hospital1112026
ImaginAb, Inc.For profit1012024
Maastricht UniversityAcademic/Hospital1112023
National Cancer Institute (NCI)Government1112022
NiKang Therapeutics, Inc.For profit1112023
Radboud UniversityAcademic/Hospital1112024
TCR2 TherapeuticsFor profit1112019
The University of Texas, DallasAcademic/Hospital1112022
University of TuebingenAcademic/Hospital1012024
10 organizations
Page 1 / 1